No abstract available
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Clinical Trials as Topic / statistics & numerical data
-
Data Collection / methods
-
Data Collection / statistics & numerical data
-
Diabetes Mellitus, Type 1 / complications
-
Diabetes Mellitus, Type 1 / drug therapy*
-
Diabetes Mellitus, Type 2 / complications
-
Diabetes Mellitus, Type 2 / drug therapy
-
Diabetic Ketoacidosis / chemically induced
-
Diabetic Ketoacidosis / epidemiology*
-
Drug Approval / organization & administration*
-
Drug Approval / statistics & numerical data
-
Glycosides / administration & dosage
-
Glycosides / adverse effects*
-
Humans
-
Phlorhizin / administration & dosage
-
Phlorhizin / adverse effects
-
Sodium-Glucose Transporter 2 Inhibitors / administration & dosage
-
Sodium-Glucose Transporter 2 Inhibitors / adverse effects*
-
Treatment Outcome
-
United States / epidemiology
-
United States Food and Drug Administration
Substances
-
Glycosides
-
Sodium-Glucose Transporter 2 Inhibitors
-
(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol
-
Phlorhizin